362 filings
Page 7 of 19
8-K
58uljqesmp1
18 Jun 19
Millendo Therapeutics Announces Departure of Chief Medical Officer
8:45am
8-K
6a2tq73t ce7r56b
13 Jun 19
Departure of Directors or Certain Officers
4:58pm
DEFA14A
npzbd5k4k
29 Apr 19
Additional proxy soliciting materials
4:51pm
EFFECT
pg77qxqay4wq4am
19 Apr 19
Notice of effectiveness
12:15am
8-K
pwsr1 2fqn9uv5wz8
17 Apr 19
Entry into a Material Definitive Agreement
4:15pm
CORRESP
o7t civgozoq1nhqj
16 Apr 19
Correspondence with SEC
12:00am
UPLOAD
uksymguifqsdzxa0rb
12 Apr 19
Letter from SEC
12:00am
S-8
4g340v nu
5 Apr 19
Registration of securities for employees
5:15pm
8-K
ux5zd7
29 Mar 19
Millendo Reports Full Year 2018 Operating and Financial Results
7:20am
8-K
kmu54vk
22 Mar 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation March 2019
5:14pm
8-K
7xop9ag 0a5z
7 Feb 19
Entry into a Material Definitive Agreement
5:27pm
8-K
11sfsmygit saa0yl
22 Jan 19
Millendo Therapeutics Reports Inducement Grants
5:17pm
8-K
3u8qtaiqsj0g3
7 Jan 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019
8:54am
424B3
d0ryiyo6dz
20 Dec 18
Prospectus supplement
4:19pm